EUVIMEDEUVIMED entdecken
Crossref

‌DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE

Hany E. A. Ahmed, Abdullah Ashraf

Al-Azhar Journal of Pharmaceutical Sciences · 14.05.2026 · 143-157

DOI: 10.21608/ajps.2026.504589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Azhar Journal of Pharmaceutical Sciences, online erschienen am 14.05.2026. Verfasst von Hany E. A. Ahmed und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ahmed, H. E. A., & Ashraf, A. (2026). ‌DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE. Al-Azhar Journal of Pharmaceutical Sciences, 0(0), 143-157. https://doi.org/10.21608/ajps.2026.504589

Vancouver

Ahmed HEA, Ashraf A. ‌DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE. Al-Azhar Journal of Pharmaceutical Sciences. 2026;0(0):143-157. doi:10.21608/ajps.2026.504589

BibTeX
@article{Ahmed2026,
  author = {Ahmed, Hany E. A. and Ashraf, Abdullah},
  title = {‌DISCOVERY OF A NOVEL PHENYLAMINE-PURINE CHEMOTYPE AS A POTENTIAL EGFR INHIBITOR USING AN INTEGRATED AI-DRIVEN DRUG DESIGN PIPELINE},
  journal = {Al-Azhar Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {143--157},
  doi = {10.21608/ajps.2026.504589}
}
Kostenlos starten →